Prof. Atsushi Asakura

University of Minnesota, USA

Email: asakura@umn.edu

Qualifications

1993 Ph.D., University of Tokyo Graduate School, Molecular Biology
1987 M.Sc., Chiba University Graduate School, Biology
1984 B.Sc., Chiba University, Biology

Publications (Selected)

1. Karthikeyan, S., Asakura, Y., Verma, M., & Asakura, A. (2025). Protocol for the three-dimensional analysis of rodent skeletal muscle. STAR protocols, 6(1), 103549.
2. Sakurai, H., Suzuki, M., & Asakura, A. (2025). Induced pluripotent stem cells (iPSCs) for skeletal muscle diseases. Frontiers in Cell and Developmental Biology, 13, 1556403.
3. Verma, M., Asakura, Y., Wang, X., Zhou, K., Ünverdi, M., Kann, A. P., ... & Asakura, A. (2024). Endothelial cell signature in muscle stem cells validated by VEGFA-FLT1-AKT1 axis promoting survival of muscle stem cell. Elife, 13, e73592.
4. Karthikeyan, S., & Asakura, A. (2024). Imaging analysis for muscle stem cells and regeneration. Frontiers in Cell and Developmental Biology, 12, 1411401.
5. Karthikeyan, S., Asakura, Y., Verma, M., & Asakura, A. (2023). Tissue clearing and confocal microscopic imaging for skeletal muscle. In Skeletal Muscle Stem Cells: Methods and Protocols (pp. 453-462). New York, NY: Springer US.
6. Karthikeyan, S., Kim, K., Asakura, Y., Verma, M., & Asakura, A. (2023). Three-dimensional imaging analysis for skeletal muscle. In Skeletal Muscle Stem Cells: Methods and Protocols (pp. 463-477). New York, NY: Springer US.
7. Vargas‐Franco, D., Kalra, R., Draper, I., Pacak, C. A., Asakura, A., & Kang, P. B. (2022). The Notch signaling pathway in skeletal muscle health and disease. Muscle & Nerve, 66(5), 530-544.
8. Den Hartog, L., & Asakura, A. (2022). Implications of notch signaling in duchenne muscular dystrophy. Frontiers in Physiology, 13, 984373.
9. Fujimaki, S., Matsumoto, T., Muramatsu, M., Nagahisa, H., Horii, N., Seko, D., ... & Ono, Y. (2022). The endothelial Dll4–muscular Notch2 axis regulates skeletal muscle mass. Nature metabolism, 4(2), 180-189.
10. Ortuste Quiroga, H. P., Ganassi, M., Yokoyama, S., Nakamura, K., Yamashita, T., Raimbach, D., ... & Goto, K. (2022). Fine-tuning of Piezo1 expression and activity ensures efficient myoblast fusion during skeletal myogenesis. Cells, 11(3), 393.
11. Bosco, J., Zhou, Z., Gabriëls, S., Verma, M., Liu, N., Miller, B. K., ... & Keefe, D. (2021). VEGFR-1/Flt-1 inhibition increases angiogenesis and improves muscle function in a mouse model of Duchenne muscular dystrophy. Molecular Therapy Methods & Clinical Development, 21, 369-381.
12. Katoku-Kikyo, N., Paatela, E., Houtz, D. L., Lee, B., Munson, D., Wang, X., ... & Kikyo, N. (2021). Per1/Per2–Igf2 axis–mediated circadian regulation of myogenic differentiation. Journal of Cell Biology, 220(7), e202101057.
13. Bosnakovski, D., Shams, A. S., Yuan, C., Da Silva, M. T., Ener, E. T., Baumann, C. W., ... & Kyba, M. (2020). Transcriptional and cytopathological hallmarks of FSHD in chronic DUX4-expressing mice. The Journal of clinical investigation, 130(5), 2465-2477.
14. Bosnakovski, D., Shams, A. S., Yuan, C., Da Silva, M. T., Ener, E. T., Baumann, C. W., ... & Kyba, M. (2020). Transcriptional and cytopathological hallmarks of FSHD in chronic DUX4-expressing mice. The Journal of clinical investigation, 130(5), 2465-2477.
15. Verma, M., Shimizu-Motohashi, Y., Asakura, Y., Ennen, J. P., Bosco, J., Zhou, Z., ... & Asakura, A. (2019). Inhibition of FLT1 ameliorates muscular dystrophy phenotype by increased vasculature in a mouse model of Duchenne muscular dystrophy. PLoS genetics, 15(12), e1008468.

Profile Details

WoS ResearcherID: H-2745-2019

https://orcid.org/0000-0001-8078-1027

https://med.umn.edu/bio/atsushi-asakura

https://scholar.google.com/citations?user=BfHZsMoAAAAJ&hl=en

https://www.linkedin.com/in/atsushi-asakura-903bb032/